Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated by Analysts at Stifel Nicolaus

Stifel Nicolaus started coverage on shares of Kestra Medical Technologies (NASDAQ:KMTSFree Report) in a report published on Monday morning, MarketBeat reports. The brokerage issued a buy rating and a $28.00 price objective on the stock.

Kestra Medical Technologies Trading Up 4.6 %

Shares of NASDAQ KMTS opened at $25.70 on Monday. Kestra Medical Technologies has a 12-month low of $20.00 and a 12-month high of $26.06.

About Kestra Medical Technologies

(Get Free Report)

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.

Recommended Stories

Analyst Recommendations for Kestra Medical Technologies (NASDAQ:KMTS)

Receive News & Ratings for Kestra Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kestra Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.